Gruppe Zydus Lifesciences Limited

Manufactures health and wellness products

Distributes pharmaceuticals and cosmetics products

Zydus Vtec Ltd., operating under the Zydus Group, is a research-driven, vertically Indian integrated pharmaceutical company with a 70-year legacy. Zydus Vtec focuses on innovation in new chemical entities, biologics, biosimilars, vaccines, and niche technologies, supported by over 1,300 researchers at 19 sites including the Zydus Research Centre. The company is based in Ahmedabad, India. The company has a strong presence across regulated and emerging markets worldwide, employing over 27,000 people and operating more than 30 manufacturing and R&D facilities. Its product portfolio includes formulations, active pharmaceutical ingredients, vaccines, biosimilars, animal health, and wellness products across therapeutic areas such as cardio-metabolic diseases, immunology, oncology, neurosciences, rare and infectious diseases. The company has developed products such as Lipaglyn™ for diabetic dyslipidemia, a biosimilar of adalimumab for autoimmune disorders, Twinrab™ for rabies, Vaxiflu-4™ for influenza, and ZyCoV-D® for COVID-19. Its vaccine pipeline includes candidates for hepatitis E, HPV, typhoid, chikungunya, and varicella, and it is developing therapies for anemia and inflammatory diseases. Zydus Vtec emphasizes quality manufacturing, regulatory compliance, sustainability, and scientific collaboration.